image

The best stocks to buy since 1993

Our latest issue will be released in 13 days, don't miss out!

EMIS - 2091 "familiarisation" orders

September 2011

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • EMIS
  • Price:
  • 555p
Nobody would query the notion that electronic care records for patients are a good thing. It allows information sharing between health practitioners and also reduces administrative burdens and so allows the NHS to operate more efficiently. The problem is that previously the NHS has attempted to achieve this with a strategy to replace all the systems that GPs were using. GPs were reluctant to change and the government's £13bn overhaul suffered cost and time delays before falling over. But there is one company, EMIS (EMIS; 555p), which is going to prove to be a spectacular and long-term winner from all this turmoil. It has already been providing the legacy Windows-based systems that sit in a GP's office and enable him to record patient det ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe